| Trial ID: | L6703 |
| Source ID: | NCT04374578
|
| Associated Drug: |
Dulaglutide 1.5 Mg/Ml
|
| Title: |
Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
|
| Acronym: |
DIVE
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Dulaglutide 1.5 MG/ML
|
| Outcome Measures: |
Primary: Effect on glycemic variability, The FreeStyle Libre Pro (Abbott Co., Ltd) will be used to monitor glucose levels during the four weeks from the day before the first administration of the study drug, one months | Secondary: Effect on Glycemic Control, It will be assessed at baseline and after one months of treatment to determine the anti-diabetic effect of dulaglutide, one months
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Zhongshan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
100
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2020-05-08
|
| Completion Date: |
2021-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-31
|
| Locations: |
180 Fenglin Road, Shanghai, 200032, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04374578
|
